Rivasa 81 mg EC tablet; Out of specification (salicylic acid impurity)
Brand(s)
Last updated
Summary
Product
RIVASA 81mg EC tablet
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| Laboratoire Riva Inc. | RIVASA 81mg EC tablet | DIN 02420279 | Tablet (Delayed-Release) | Acetylsalicylic acid 81 mg | 3G4865SUK |
Issue
The dosage of free salicylic acid impurity may be out of specification in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Related recalls and alerts
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Laboratoire Riva Inc.
660 Boul. Industriel
Blainville Quebec J7C 3V4 Canada
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-77564
Get notified
Receive notifications for new and updated recalls and alerts by category.